Platelets act to initiate an invasive mesenchymal phenotype through the liberation of TGFβ1 and ATP from granules, thereby inducing endothelial junction modification and enhancing transendothelial migration of cancer cells [276,355,356]. This evidence concerns the gene TGFB1 and cancer.